The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Weight gain from novel antipsychotic drugs: need for action
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Self-citationWeight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men
Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome
Ferrannini, E., Haffner, S. M., Mitchell, B. D., & Stern, M. P. (1991) · Diabetologia · doi:10.1007/bf00403180 · Cited by 898
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Neuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Research works printed but not linked: 137
- Andreasen, 1999, Understanding the causes of schizophrenia, N Eng J Med, 340, 645, 10.1056/NEJM199902253400811 · DOI
- Ho, 1997, Dependence on public financial support early in the course of schizophrenia, Psychiatr Serv, 48, 948, 10.1176/ps.48.7.948 · DOI
- Cohen, 1990, Suicide and schizophrenia, Am J Psychiatry, 147, 602, 10.1176/ajp.147.5.602 · DOI · Paper page
- Axelsson, 1992, Factors predicting suicide in psychotic patients, Eur Arch Psychiatr Clin Neurosci, 241, 259, 10.1007/BF02195974 · DOI
- Bernstein, 1987, Induction of obesity by psychotropic drugs, Ann NY Acad Sci, 499, 203, 10.1111/j.1749-6632.1987.tb36212.x · DOI
- Allison, 1999, The distribution of body mass index among individuals with and without schizophrenia, J Clin Psychiatry, 60, 215, 10.4088/JCP.v60n0402 · DOI · Paper page
- Beasley CM: Safety of olanzapine. J Clin Psychiatry Monograph 1997a;15(2):19–21, 1997a
- Stanton, 1995, Weight gain associated with neuroleptic medication, Schizophr Bull, 21, 463, 10.1093/schbul/21.3.463 · DOI
- Kando, 1997, Olanzapine, Ann Pharmacother, 31, 1325, 10.1177/106002809703101110 · DOI
- Umbricht, 1994, Clozapine and weight gain, J Clin Psychiatry, 55, 157
- 1998, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report, Obes Res, 6, 51S
- Pijl, 1996, Body weight change as an adverse effect of drug treatment, Drug Safety, 14, 329, 10.2165/00002018-199614050-00005 · DOI
- Andreasen, 1998, “Cognitive dysmetria” as an integrative theory of schizophrenia, Schizophr Bull, 24, 203, 10.1093/oxfordjournals.schbul.a033321 · DOI · Paper page
- Woods, 1998, Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenic mechanism, Am J Psychiatry, 155, 1661, 10.1176/ajp.155.12.1661 · DOI · Paper page
- Jones, 1991, The genetics of schizophrenia is the genetics of neurodevelopment, Br J Psychiatry, 158, 615, 10.1192/bjp.158.5.615 · DOI · Paper page
- Armstrong, 1995, The ontogeny of human gyrification, Cereb Cortex, 5, 56, 10.1093/cercor/5.1.56 · DOI · Paper page
- McGlashan, 1988, A selective review of recent North American long-term follow-up studies of schizophrenia, Schizophr Bull, 14, 514
- Eaton, 1992, Long-term course of hospitalization for schizophrenia, Schizophr Bull, 18, 217, 10.1093/schbul/18.2.217 · DOI · Paper page
- Kenny, 1991, Attention of higher cortical functions in schizophrenia, J Neuropsychiatr Clin Neurosci, 3, 269, 10.1176/jnp.3.3.269 · DOI
- Saykin, 1991, Neuropsychological function in schizophrenia, Arch Gen Psychiatry, 48, 618, 10.1001/archpsyc.1991.01810310036007 · DOI · Paper page
- Seidman, 1995, Experimental and clinical neuropsychological measures of prefrontal dysfunction in schizophrenia, Neuropsychology, 9, 481, 10.1037/0894-4105.9.4.481 · DOI
- Bellack, 1992, Cognitive rehabilitation for schizophrenia, Schizophr Bull, 18, 43, 10.1093/schbul/18.1.43 · DOI
- Jaeger, 1992, Remediation of neuropsychological deficits in psychiatric populations, Psychopharmacol Bull, 28, 367
- Regier, 1990, Comorbidity of mental disorders with alcohol and other drug abuse, JAMA, 264, 2511, 10.1001/jama.264.19.2511 · doi:10.1001/jama.264.19.2511 · Paper page
- Green, 1999, Substance use disorder and schizophrenia, Harv Rev Psychiatry, 6, 289
- Tsuang, 1978, Suicide in schizophrenics, manics, depressives, and surgical controls, Arch Gen Psychiatry, 35, 153, 10.1001/archpsyc.1978.01770260031002 · DOI · Paper page
- Meltzer, 1995, Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia, Am J Psychiatry, 152, 183, 10.1176/ajp.152.2.183 · DOI · Paper page
- Davis, 1975, Overview, Am J Psychiatry, 132, 1237, 10.1176/ajp.132.12.1237 · DOI · Paper page
- Marder, 1994, Risperidone in the treatment of schizophrenia, Am J Psychiatry, 151, 825, 10.1176/ajp.151.6.825 · DOI · Paper page
- Meltzer, 1994, Recent advances in the pharmacotherapy of schizophrenia, Acta Psychiatr Scand Suppl, 384, 95, 10.1111/j.1600-0447.1994.tb05897.x · DOI
- Kane J: Olanzapine in the long-term treatment of schizophrenia. Br J Psychiatry 1999;174(suppl 37):26–29 · DOI
- Kane, 1988, Clozapine Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic, Arch Gen Psychiatry, 45, 789, 10.1001/archpsyc.1988.01800330013001 · DOI · Paper page
- Jibson, 1996, A summary of research findings on the new antipsychotic drugs, Essent Psychopharmacol, 1, 27
- Small, 1997, Quetiapine inpatients with schizophrenia, Arch Gen Psychiatry, 54, 549, 10.1001/archpsyc.1997.01830180067009 · DOI · Paper page
- Bymaster, 1999, Olanzapine, Br J Psychiatry, 174, 36, 10.1192/S0007125000293653 · DOI
- Breier, 1994, Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia, Am J Psychiatry, 151, 20, 10.1176/ajp.151.1.20 · DOI · Paper page
- Green, 1995, Should clozapine be a first-line treatment for schizophrenia, Harv Rev Psychiatry, 3, 1, 10.3109/10673229509017159 · DOI
- Stone, 1997, Effects of clozapine on cognitive functioning in treatment-refractory schizophrenia, Schizophrenia Res, 24, 188, 10.1016/S0920-9964(97)82539-X · doi:10.1016/s0920-9964(97)82539-x
- Breier, 1999, Cognitive deficit in schizophrenia and its neurochemical basis, Br J Psych, 174, 16, 10.1192/S0007125000293604 · DOI
- Lindstrom, 1988, The effect of long-term treatment with clozapine in schizophrenia, Acta Psychiatr Scand, 77, 524, 10.1111/j.1600-0447.1988.tb05164.x · DOI · Paper page
- Meltzer, 1992, Dimensions of outcome with clozapine, Br J Psychiatry, 160, 46, 10.1192/S000712500029692X · DOI · Paper page
- Albanese, 1994, Decreased substance use in chronically psychotic patients treated with clozapine, Am J Psychiatry, 151, 780, 10.1176/ajp.151.5.780b · DOI
- Drake RE, Xie H, McHugo GJ, Green AI: The effects of clozapine on alcohol and drug use disorders among schizophrenic patients. Schizophr Bull, in press
- Gerlach, 1994, Motor and mental side effects of clozapine, J Clin Psychiatry, 55, 107
- Kerwin, 1994, The new atypical antipsychotics, Br J Psychiatry, 164, 141, 10.1192/bjp.164.2.141 · DOI · Paper page
- McGlashan, 1996, Early detection and intervention in schizophrenia research, Schizophrenia Bull, 22, 327, 10.1093/schbul/22.2.327 · DOI · Paper page
- Post, 1956, Body-weight changes in psychiatric illness, J Psychosom Res, 1, 219, 10.1016/0022-3999(56)90025-3 · doi:10.1016/0022-3999(56)90025-3
- Amdisen, 1964, Drug-produced obesity, Dan Med Bull, 11, 182
- Caffey, 1971, Experience with large scale interhospital co-operative research in chemotherapy, Am J Psychiatry, 117, 713, 10.1176/ajp.117.8.713 · doi:10.1176/ajp.117.8.713
- Doss, 1979, The effect of antipsychotic drugs on body weight, J Clin Psychiatry, 40, 528
- Silverstone, 1988, Prevalence of obesity in patients receiving depot antipsychotics, Br J Psychol, 153, 214, 10.1192/bjp.153.2.214 · DOI
- Stedman, 1993, The distribution of adipose tissue in female inpatients receiving psychotropic drugs, Br J Psychiatry, 162, 249, 10.1192/bjp.162.2.249 · DOI
- Centorrino, 1994, Clozapine and metabolites, J Clin Psychopharmacol, 14, 119, 10.1097/00004714-199404000-00006 · DOI
- Wirshing, 1998, Novel antipsychotics and new onset diabetes, Biol Psychiatry, 44, 778, 10.1016/S0006-3223(98)00100-0 · DOI · Paper page
- Leadbetter, 1992, Clozapine-induced weight gain, Am J Psychiatry, 149, 68, 10.1176/ajp.149.1.68 · DOI · Paper page
- Casey, 1996, Side effect profiles of new antipsychotic agents, J Clin Psychiatry, 57, 40
- Kane, 1997, What are the therapeutic needs in schizophrenia and how are they satisfied by new antipsychotics?, Int Clin Psychopharmacol, 12, S3, 10.1097/00004850-199705002-00002 · DOI
- Beasley, 1997, Safety of olanzapine, J Clin Psychiatry, 58, 13
- Bromel, 1998, Serum leptin levels increase rapidly after initiation of clozapine therapy, Mol Psychiatry, 3, 76, 10.1038/sj.mp.4000352 · DOI · Paper page
- Sussman, 1999, Effects of psychotropic drugs on weight, Psychiatric Ann, 29, 580, 10.3928/0048-5713-19991001-08 · doi:10.3928/0048-5713-19991001-08
- Lamberti, 1992, Weight gain among schizophrenic patients treated with clozapine, Am J Psychiatry, 149, 689, 10.1176/ajp.149.5.689 · doi:10.1176/ajp.149.5.689
- Bustillo, 1996, Differential effect of clozapine on weight, Am J Psychiatry, 153, 817, 10.1176/ajp.153.6.817 · DOI
- Wirshing, 1999, Novel antipsychotics, J Clin Psychiatry, 60, 358, 10.4088/JCP.v60n0602 · DOI · Paper page
- Kelly, 1998, Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months, J Child Adolesc Psychopharmacol, 8, 151, 10.1089/cap.1998.8.151 · DOI
- McDougle, 1998, A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders, Arch Gen Psych, 55, 633, 10.1001/archpsyc.55.7.633 · DOI · Paper page
- Young, 1986, Medication compliance in schizophrenia, Bull Am Acad Psychiatry Law, 14, 105
- Robinson, 1999, Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder, Arch Gen Psychiatry, 56, 241, 10.1001/archpsyc.56.3.241 · DOI · Paper page
- Lieberman, 1996, Atypical antipsychotic drugs as a first-line treatment of schizophrenia, J Clin Psychiatry, 57, 68
- Robinson, 1975, Measurement of appetite disturbances in psychiatric disorders, J Psychiatr Res, 12, 59, 10.1016/0022-3956(75)90021-7 · DOI
- Cookson, 1991, Side effects during long-term treatment with a depot antipsychotic medication, Clin Neuropharm, 14, S24
- Mukherjee, 1996, Diabetes mellitus in schizophrenic patients, Compr Psychiatry, 37, 68, 10.1016/S0010-440X(96)90054-1 · DOI · Paper page
- McKee, 1986, Diabetes and schizophrenia—a preliminary study, J Clin Hosp Pharm, 11, 297
- Tsuang, 1993, Physical diseases in schizophrenia and affective disorder, J Clin Psychiatry, 44, 42
- Brambilla, 1976, Glucose-insulin metabolism in chronic schizophrenia, Dis Nerv Syst, 37, 98
- Williamson, 1993, Descriptive epidemiology of body weight and weight change in U.S. adults, Ann Intern Med, 119, 646, 10.7326/0003-4819-119-7_Part_2-199310011-00004 · DOI · Paper page
- Gill, 1997, Key issues in the prevention of obesity, Br Med Bull, 53, 359, 10.1093/oxfordjournals.bmb.a011618 · DOI
- Lee, 1992, Change in body weight and longevity, JAMA, 268, 2045, 10.1001/jama.268.15.2045 · DOI
- Rimm, 1995, Body size and fat distribution as markers of coronary heart disease among young and older men, Am J Epidemiol, 141, 1117, 10.1093/oxfordjournals.aje.a117385 · DOI · Paper page
- Liese, 1998, Development of the multiple metabolic syndrome, Epidemiol Rev, 20, 157, 10.1093/oxfordjournals.epirev.a017978 · DOI · Paper page
- Maggio, 1997, The prevention and treatment of obesity. Application to type 2 diabetes, Diabetes Care, 20, 1744, 10.2337/diacare.20.11.1744 · DOI · Paper page
- Blackburn, 1995, Effect of degree of weight loss on health benefits, Obes Res, 3, 211S, 10.1002/j.1550-8528.1995.tb00466.x · DOI · Paper page
- Ferrannini, 1993, Syndrome X, Horm Res, 39, 107, 10.1159/000182795 · DOI
- Reaven, 1993, Role of insulin resistance in human disease (syndrome X), Annu Rev Med, 44, 121, 10.1146/annurev.me.44.020193.001005 · DOI · Paper page
- Mantzoros, 1995, Insulin resistance, Adv Endocrinol Metab, 6, 193
- Everson, 1998, Weight gain and the risk of developing insulin resistance syndrome, Diabetes Care, 21, 1637, 10.2337/diacare.21.10.1637 · DOI
- Eckel, 1998, American Heart Association call to action, Circulation, 97, 2099, 10.1161/01.CIR.97.21.2099 · DOI · Paper page
- Schultz, 1999, Impaired glucose tolerance and abnormal movements in patients with schizophrenia, Am J Psychiatry, 156, 640, 10.1176/ajp.156.4.640 · doi:10.1176/ajp.156.4.640
- Glenny, 1997, The treatment and prevention of obesity, Int J Obes, 21, 715, 10.1038/sj.ijo.0800495 · DOI · Paper page
- Kramer, 1986, Maintenance of successful weight loss over 1 year, Behaviour Therapy, 17, 295, 10.1016/S0005-7894(86)80058-2 · DOI
- Ditschuneit, 1999, Metabolic and weight loss effects of long-term dietary intervention in obese patients, Am J Clin Nutr, 69, 198, 10.1093/ajcn/69.2.198 · DOI · Paper page
- Pronk, 1994, Physical activity and long-term maintenance of weight loss, Obes Res, 2, 587, 10.1002/j.1550-8528.1994.tb00110.x · DOI · Paper page
- Baum, 1991, Preventing relapse in obesity through post-treatment maintenance systems, J Behavioral Med, 14, 287, 10.1007/BF00845456 · DOI
- Miura, 1989, The long term effectiveness of combined therapy by behavior modification and very low calorie diet, Inter J Obes, 13, 73
- Wadden, 1997, Lifestyle modifications in the pharmacologic treatment of obesity, Obes Res, 5, 218, 10.1002/j.1550-8528.1997.tb00296.x · DOI
- Rotatori, 1980, Weight loss with psychiatric residents in a behavioral self-control program, Psychological Rep, 46, 483, 10.2466/pr0.1980.46.2.483 · DOI
- Ferster, 1962, The control of eating, J Mathetics, 1, 87
- Knox, 1980, A study of weight reducing diets in psychiatric in-patients, Br J Psychia, 136, 287, 10.1192/bjp.136.3.287 · DOI
- Klien, 1972, Reinforcement and weight loss in schizophrenics, Psycol Rep, 30, 581, 10.2466/pr0.1972.30.2.581 · DOI
- Stuart, 1967, Behavioral control of overeating, Behav Res Ther, 5, 357, 10.1016/0005-7967(67)90027-7 · DOI · Paper page
- Menditto, 1996, Effectiveness of clozapine and a social learning program for severely disabled psychiatric inpatients, Psychiatric Services, 47, 46, 10.1176/ps.47.1.46 · doi:10.1176/ps.47.1.46
- Smith, 1996, Training hospitalized patients with schizophrenia in community reintegration skills, Psychiatric Services, 47, 1099, 10.1176/ps.47.10.1099 · DOI
- Goisman, 1998, Social skills training, atypical neuroleptics and treatment-refractory psychosis, Int Rev Psychiatry, 10, 84, 10.1080/09540269875168 · doi:10.1080/09540269875168
- Liberman, 1994, Optimal drug and behavior therapy for treatment-refractory schizophrenic patients, Am J Psychiatry, 151, 756, 10.1176/ajp.151.5.756 · DOI
- Psychiatric Rehabilitation Consultants: Social and independent living skills: symposium management module trainer’s manual. 1988
- Liberman, 1993, Innovations in skills training for the seriously mentally ill, Innovations Res, 2, 43
- Dengel, 1998, Improvements in blood pressure, glucose metabolism and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men, Metabolism, 47, 1075, 10.1016/S0026-0495(98)90281-5 · DOI
- DiPietro, 1998, Moderate-intensity aerobic training improves glucose tolerance in aging independent of abdominal adiposity, J Am Geriatr Soc, 46, 875, 10.1111/j.1532-5415.1998.tb02722.x · DOI
- Segal, 1991, Effect of exercise training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic men, J Appl Physiol, 71, 2402, 10.1152/jappl.1991.71.6.2402 · DOI · Paper page
- Pratt, 1999, Benefits of lifestyle activity versus structured exercise, JAMA, 281, 375, 10.1001/jama.281.4.375 · DOI
- Sallis, 1998, Environmental and policy interventions to promote physical activity, Am J Prev Med, 15, 379, 10.1016/S0749-3797(98)00076-2 · DOI · Paper page
- Yanovski, 1996, National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity, JAMA, 276, 1907, 10.1001/jama.276.23.1907 · DOI
- Goldstein, 1992, Beneficial health effects of modest weight loss, Int J Obes, 16, 379
- Atkinson, 1994, Report on the NIH Workshop on Pharmacologic Treatment of Obesity, Am J Clin Nutr, 60, 153, 10.1093/ajcn/60.2.153 · DOI
- Weintraub, 1981, Determinants of response to anorexiants, Clin Pharmacol Ther, 30, 528, 10.1038/clpt.1981.198 · DOI
- Bray, 1999, Sibutramine produces dose-related weight loss, Obes Res, 7, 189, 10.1002/j.1550-8528.1999.tb00701.x · DOI · Paper page
- Cleare, 1996, Phentermine, psychosis, and family history, J Clin Psychopharmacol, 16, 470, 10.1097/00004714-199612000-00020 · doi:10.1097/00004714-199612000-00020
- Devan, 1990, Phentermine and psychosis, Br J Psychiatry, 156, 442, 10.1192/bjp.156.3.442 · doi:10.1192/bjp.156.3.442
- Shannon, 1974, Fenfluramine and psychosis, Br Med J, 3, 576, 10.1136/bmj.3.5930.576-b · DOI
- Bagri, 1998, Delerium with manic symptoms induced by diet pills, J Clin Psychiatry, 59, 83, 10.4088/JCP.v59n0207d · doi:10.4088/jcp.v59n0207d
- Khan, 1987, Psychotomimetic effects of anorectic drugs, Am Fam Physician, 36, 107
- Dietz, 1981, Amphetamine-like reactions to phenylpropanolamine, JAMA, 245, 601, 10.1001/jama.245.6.601 · DOI
- Schaeffer, 1980, Psychotic reaction caused by proprietary oral diet agents, Am J Psychiatry, 137, 1256, 10.1176/ajp.137.10.1256 · doi:10.1176/ajp.137.10.1256
- Ryan, 1995, Sibutramine, Obes Res, 3, 553S, 10.1002/j.1550-8528.1995.tb00227.x · DOI
- Bray, 1996, A double-blind randomized placebo-controlled trial of sibutramine, Obes Res, 263, 10.1002/j.1550-8528.1996.tb00544.x · DOI · Paper page
- Weintraub, 1992, Long-term weight control study, Clin Pharmacol Therapeut, 51, 642, 10.1038/clpt.1992.76 · DOI · Paper page
- Scheen AJ, Lefebvre PJ: Pharmacological treatment of obesity: present status. Int J Obes Relat Metab Disord 23(suppl 1):S47–S53, 1999 · DOI
- Apfelbaum, 1999, Long-term maintenance of weight loss after a very-low-calorie diet, Am J Med, 106, 179, 10.1016/S0002-9343(98)00411-2 · DOI · Paper page
- Guerciolini, 1997, Mode of action of orilistat, Int J Obes Relat Metab Disord, 21, S12
- Bray, 1998, Obesity, Lancet, 352, 160, 10.1016/S0140-6736(98)22029-0 · DOI
- Gaal, 1998, Efficacy and tolerability of orlistat in the treatment of obesity, Eur J Clin Pharmacol, 54, 125, 10.1007/s002280050433 · DOI
- Sjostrom, 1998, Randomised placebo-controlled trial for orlistat for weight loss and prevention of weight gain in obese patients, Lancet, 352, 167, 10.1016/S0140-6736(97)11509-4 · DOI · Paper page
- McNeely, 1998, Orlistat, Drugs, 56, 241, 10.2165/00003495-199856020-00007 · DOI
- Zhi, 1996, The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers, Pharmacology, 36, 152
- Melia, 1996, The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers, J Clin Pharmacol, 36, 647, 10.1002/j.1552-4604.1996.tb04230.x · DOI
- Ayllon, 1963, Intensive treatment of psychotic behavior by stimulus satiation and food reinforcement, Behav Res Ther, 21, 53, 10.1016/0005-7967(63)90008-1 · DOI
- Bernard, 1968, Rapid treatment of gross obesity by operant techniques, Psychol Rep, 23, 663, 10.2466/pr0.1968.23.2.663 · DOI
- Harmatz, 1968, Behavior modification of overeating in a psychiatric population, JCCP, 32, 583
Cited by
Clinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 995
Nordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778
Integrating Physical Activity Into Mental Health Services for Persons With Serious Mental Illness
Richardson, C. R., Faulkner, G., McDevitt, J., Skrinar, G. S., Hutchinson, D. S., & Piette, J. D. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.3.324 · Cited by 493
Levkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., & Kron, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04666yel · Cited by 387
Álvarez-Jiménez, M., Hetrick, S. E., González-Blanch, C., Gleeson, J. F., & McGorry, P. D. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.042853 · Cited by 317
Metadata
- Authors
- Green, A. I., Patel, J. K., Goisman, R. M., Allison, D. B., & Blackburn, G.
- Venue
- General Hospital Psychiatry
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 22
- Issue
- 4
- Pages
- 224-235
- ISSN
- 0163-8343 (ISSN-L)
- OpenAlex
- W1977544418
- Cited by
- 170
- References
- 12
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Weight gain from novel antipsychotic drugs: need for action. https://app.cochat.ai/papers/10.1016/s0163-8343(00)00081-5
- The paper
- Green, A. I., Patel, J. K., Goisman, R. M., Allison, D. B., & Blackburn, G. (2000). Weight gain from novel antipsychotic drugs: need for action. General Hospital Psychiatry. https://doi.org/10.1016/s0163-8343(00)00081-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.